Alliance Pharma PLC Capital Markets Event (2558R)
December 08 2016 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 2558R
Alliance Pharma PLC
08 December 2016
For immediate release 8 December 2016
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Capital Markets Event
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, will this afternoon host a capital markets event for
equity analysts and institutional investors. The event will provide
a detailed insight into the Company's prospects following its
transformational acquisition of the healthcare products business of
Sinclair IS Pharma plc in December 2015.
The capital markets event will take place at the offices of
Buchanan, 107 Cheapside, London, EC2V 6DN, and will start at 2.30pm
with an introduction by John Dawson, Alliance Pharma's CEO. It will
then include presentations on various aspects of Alliance's
business from the wider management team.
Analysts and investors who are not already registered to attend
the event but who would like to attend please contact Buchanan at
the details below.
No new material information will be disclosed at the event.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial
Officer
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: James
Black / Toby Adcock
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCTRBRTMBAMBRF
(END) Dow Jones Newswires
December 08, 2016 02:00 ET (07:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024